Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.86
-1.07 (-6.72%)
At close: Mar 6, 2026, 4:00 PM EST
15.15
+0.29 (1.95%)
After-hours: Mar 6, 2026, 6:37 PM EST

Adaptive Biotechnologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,2882,4978877111,0933,968
Market Cap Growth
85.89%181.67%24.72%-34.98%-72.44%-51.25%
Enterprise Value
2,2582,347743.27453.77693.833,721
Last Close Price
14.8616.246.004.907.6428.06
PE Ratio
--41.64-5.56-3.14-5.46-18.96
PS Ratio
8.269.024.954.185.9025.71
PB Ratio
10.4411.414.372.312.366.57
P/TBV Ratio
10.3111.264.352.292.356.52
P/FCF Ratio
--51.02-8.97-4.26-5.46-15.59
P/OCF Ratio
--54.31-9.31-4.55-5.94-20.59
EV/Sales Ratio
8.158.474.152.663.7424.11
EV/EBITDA Ratio
--59.73-5.19-2.22-3.87-19.08
EV/EBIT Ratio
--41.08-4.57-2.00-3.47-17.81
EV/FCF Ratio
--47.95-7.52-2.72-3.46-14.62
Debt / Equity Ratio
0.310.310.390.290.210.18
Debt / EBITDA Ratio
-2.01-2.01-0.62-0.48-0.60-0.57
Debt / FCF Ratio
-1.62-1.62-0.90-0.59-0.54-0.44
Net Debt / Equity Ratio
-0.68-0.68-0.66-0.80-0.84-0.40
Net Debt / EBITDA Ratio
3.763.760.931.212.181.24
Net Debt / FCF Ratio
3.023.021.341.481.950.95
Asset Turnover
0.530.530.300.220.210.15
Inventory Turnover
7.827.826.305.233.442.96
Quick Ratio
3.083.082.694.374.903.26
Current Ratio
3.343.342.894.665.123.54
Return on Equity (ROE)
-27.82%-27.82%-62.49%-58.34%-37.52%-30.77%
Return on Assets (ROA)
-10.86%-10.86%-27.08%-29.92%-22.49%-20.49%
Return on Invested Capital (ROIC)
-21.14%-21.14%-56.98%-74.84%-46.34%-44.38%
Return on Capital Employed (ROCE)
-13.22%-13.22%-32.05%-34.40%-25.72%-22.95%
Earnings Yield
-2.60%-2.40%-18.00%-31.84%-18.32%-5.27%
FCF Yield
-2.14%-1.96%-11.15%-23.49%-18.32%-6.41%
Buyback Yield / Dilution
-0.72%-0.72%-0.03%-0.32%-0.72%-0.67%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q